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Abstract
Background Lumbar spinal stenosis is a degenerative
disease of the elderly population. Although microsurgical
decompression has shown good long-term results, percuta-
neous techniques could provide an alternative in the
presence of significant comorbidities.
Method Eighty-seven interspinous process decompression
devices (In-space; Synthes, Umkirch, Germany) were
implanted percutaneously in up to three segments of 50
patients. Outcome was assessed directly after surgery, at
6–8 weeks, and at average follow-up of 1 year (11.8±
6 months). Assessment included complications, pain and
spinal claudication, neurodeficit, time to recurrence of
symptoms, and time to second surgery. Subgroups with
additional low back pain at presentation and mild spondy-
lolisthesis were analyzed separately.
Findings Intraoperative complications were rare (one
misplacement and two cases of failed implantation);
average operation time was 16.4±12.2 min per segment.
Initial response was very good with 72% good or excellent
relief of symptoms. After a 1-year follow-up, 42% reported
of lasting relief from spinal claudication. Thirteen percent
of these complained about lasting or new-onset low back
p a i n .As e c o n ds u r g e r yh a db e e np e r f o r m e di n2 2 % .
Subgroup analysis was performed for patients presenting
with additional low back pain and spondylolisthesis
patients. No significant differences could be noted between
subgroups.
Conclusions T h eI n - s p a c ei sap e r c u t a n e o u st r e a t m e n t
option of claudication in patients with lumbar spinal
stenosis. Compared with microsurgical decompression
surgery, recurrence rate within 1 year is, however, high
and the device seems not suitable for the treatment of low
back pain. Therefore, the authors suggest that the device
should presently be used primarily in controlled clinical
trials in order to get more information concerning the
optimal indication.
Keywords Interspinous process decompression (IPD).
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Introduction
Lumbar spinal stenosis is a result of degeneration of the
lumbar spine and strongly correlated with older age [20,
28]. The most common symptom is spinal claudication with
or without low back pain and alleviation in flexion of the
spine [9]. Microsurgical decompression has been shown to
adequately relieve the symptoms, and long-term results are
very good [1, 2, 7, 10, 18, 19, 29]. Unfortunately, higher
patient age is also associated with relevant comorbidity and
thus aggravating the risk of anaesthesia and prolonged
surgical procedures [3, 21, 22, 25]. Interspinous process
decompression (IPD) techniques may offer a less invasive
alternative for microsurgical decompressive surgery in
lumbar spinal stenosis. Several implants have been intro-
duced in the market. The In-space (Synthes, Umkirch,
Germany) is a new implant strictly designed for percutane-
ous implantation with short operating times. We present the
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safety of the device.
Materials and methods
Patients
Between November 2007 and August 2009, 50 patients
were treated by percutaneous implantation of the In-space
device (Synthes) in our institution (Fig. 1). Average patient
age was 71.8±10.6 years, gender ratio (male/female) was
34:16. The indication for implantation of the In-space was
based on the presence of mild to moderate lumbar spinal
stenosis as demonstrated on a preoperative magnetic
resonance or computed tomography scan in one to three
levels. Symptoms included spinal claudication in 44
patients, 16 of these had additional low back pain. One
patient presented with isolated intermittent neurodeficit,
one with isolated L5 radicular pain, and four with low back
pain and fixed radicular pain only. In 12 of the patients, a
mild spondylolisthesis (Meyerding °1) without the presence
of spondylolysis was diagnosed in one or two segments.
Preoperative treatment included oral analgetics and physio-
therapy in all cases. One patient underwent conventional
decompression surgery 2 years previously to In-space
implantation in the same segment (L3/4). Three patients
had previously been operated by conventional decompres-
sion of other segments of the lumbar spine, two had
undergone anterior discectomy of the cervicle spine, and
one patient had undergone kyphoplasty (L4) prior to In-
space implantation at L2/3.
Surgery
Up to three In-space devices were implanted percutaneous-
ly in the affected segments. Intraoperative complications as
well as time for surgery and required blood cell transfusions
were recorded. After surgery, X-ray films were obtained in
two planes to rule out/confirm misplacement of the
implants for all patients.
Follow-up
During the postoperative hospitalization, postoperative
neuroexaminations were performed and pain and mobility
were assessed in the following categories: worse, same,
slightly better, good, or excellent. Postoperative imaging
studies, other than conventional X-ray (magnetic resonance
imaging or computed tomography scans) were performed in
Fig. 1 Percutaneous implanta-
tion of the In-space device. a–c
Insertion of a guiding wire and
dilatation of the approach.
Finally, the implant is
inserted (d), and its wings were
deployed (e)
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included neuroexamination and assessment of pain, maxi-
mal pain-free walking distance (in the abovementioned
categories) 6–8 weeks after surgery. Further reevaluation
schedules included fixed and intermittent neurodeficit, pain
and pain-free walking distance (in the abovementioned
categories), subjective quality of life/contendness with
surgery, further surgery or interventions, further imaging
studies, and time to progression/recurrence of symptoms.
Results
Surgery and complications
Intraoperatively, a total of 87 In-space devices were
implanted in 50 patients in up to three adjacent segments.
Level L4/5 was operated most frequently (36 cases)
followed by L3/4 (29), L2/3 (18), and L5/S1 (6). In two
cases (L3/4 and L5/S1), implantation of the In-space was
impossible because of strong ossification of the interspi-
nous ligament. In one of these patients (L5/S1) who
consequently did not improve after attempted implantation
of the device microsurgical decompression was indicated,
but refused by the patient. The other case (L3/54) was
scheduled for In-space implantation at L2/3 and L3/4. The
symptomatic of this patient, however, improved much after
implantation of the device in L2/3 only (last follow-up of
this patient was 17 months after surgery).
The size of the implanted In-space devices was 8 mm in
24, 10 mm in 31, 12 mm in 17, and 14 mm in 8 cases.
Intraoperatively, the spacer size was selected to compensate
lumbar lordosis without provoking local kyphosis. Postop-
erative X-ray demonstrated dislocation of the implant in
one case (L3/4), while two other implants in the same
patient (L4/5 and L5/S1) were in place (Fig. 2). No further
dislocations were observed. Other intrasurgical complica-
tions like spinous process fractures were likewise not
observed. The average operation time was 16.4±12.2 min
per segment. No blood cell concentrates had to be
administered intraoperatively or postoperatively, and no
intraoperative or postoperative severe adverse events were
registered.
Postoperative results
During the hospitalization (1–2 days usually after surgery),
two patients (4%) complained about increased pain at the
operation site or new-onset low back pain while the spinal
claudication seemed relieved. These two patients were
categorized as “worse.” Eight patients(16%) had no improve-
ment of their symptoms and were categorized “same.” Four
patients (8%) reported of some improvement of their
symptoms (“slightly better”), and 36 patients (72%) reported
of good (31 patients, or 62%) or excellent (symptom-free, 5
patients, or 10%) relief of their symptoms.
Follow-up
During follow-up, 5 patients did not respond (two of which
had additional low back pain, none with spondylolisthesis),
and data of 45 patients (90%) could be gathered completely.
Average follow-up for these 45 patients was 1 year (11.8±
6.0 months). Patients who underwent second surgery in the
operated segment were rated as failure of therapy and no
longer followed. This happened during follow-up with 10
(22%) of the patients. In these cases, decompression
surgery and/or stabilization was performed. For the 10
Fig. 2 X-ray (a coronary plain
and b sagittal plain) of
implanted In-space devices
in the levels L3/4, L4/5, and
L5/S1. The device in level
L3/4 is the only dislocated
device observed in our cohort
(white arrow)
Acta Neurochir (2010) 152:1961–1967 1963patients who underwent second surgery, average time
between first and second surgery was 5±2 months. Sixteen
other patients (35.5%) did report of recurrent spinal
claudication, but were not yet scheduled for second surgery.
Reasons for this were either that the patient did not (yet)
wish a second procedure, or the presence of severe
comorbidity and general unfitness for prolonged anaesthe-
sia and more invasive procedures. At the time of writing up
of this report, 19 patients (42.2%) reported of lasting relief
of their claudication and radicular pain without further
treatment (Figs. 3 and 4). These patients had an average
follow-up time of 12.2% (slightly longer than the average
follow-up of the entire collective). However, 6 of these
patients (13.3%) complained about lasting (2/45) or new-
onset (4/45) low back pain.
Subgroup analysis
Patients with spondylolisthesis in one to two segments
showed fairly similar postoperative results compared with
the average patient. Eight (66.7%) of 12 patients in this
subgroup reported of good or excellent relief of symptoms,
8.3% (1/12) experienced some relief (“slightly better”), and
25% experienced no positive effect at all (“same”).
Twelve (70.6%) of 17 patients presenting with additional
low back pain experienced good or excellent initial
reduction of symptoms, 5.9% (1/17) felt a slight relief,
17.6% (3/17) noticed no significant change, and 5.9% (1/17)
reported of increased low back pain (Fig. 5a).
At last follow-up, the spondylolisthesis group was still
doing fairly similar to the average patient, with 41.7% (5/12)
reporting of lasting relief (1 of which complained about
lasting low back pain), while 8.3% (1/12) underwent second
surgery and 50% (6/12) complained of recurrent symptoms
but were not (yet) scheduled for second surgery.
The patients with additional low back pain at first
presentation fared likewise similar to the average
patient. Forty percent (6/15) reported of lasting relief,
13.3% (2/15) of which did have lasting low back pain,
whereas the other 26.7% (4/15) reported of lasting relief
also for their low back pain. Forty percent (6/15) had
undergone second surgery, and 20% (3/15) reported of
recurrent symptoms but were not yet scheduled for
second surgery (Fig. 5b).
Discussion
Techniques for surgical treatment of spinal stenosis
Conventional decompression surgery has demonstrated
good results and can be regarded as gold standard in the
treatment of lumbar spinal stenosis [1, 2, 7, 10, 18, 19, 29].
Short- and long-term results have been reported to be
excellent, with more than 92.2% of patients still improved
after 5.6 years [19]. However, the necessary removal of
bone and soft tissue can have destabilizing effects on the
operated segments, and the technique has therefore been
combined with posterior lumbar fusion [11]. In order to
provide additional stability, while avoiding longer operat-
ing times and potential risks of instrumentation with
pedicle screws, rods, and intervertebral cages, interspinous
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Fig. 4 Kaplan–Meier estimator for the time to progression/recurrence
of symptoms after implantation of an In-space device in our cohort
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Fig. 3 Follow-up of patients who received an In-space device for
lumbar spinal stenosis. At 3 months after surgery, the curve
representing patients with recurrent symptoms rises above that of
those with lasting relief from claudication. Afterward, both curves
seem to parallel each other, suggesting a comparably stable ratio of
patients with lasting relive/patients with progradient claudication
always from 3 months onward. The sum of all curves decreases to
the right of the diagram, because patients fall out of follow-up. A
second surgery was first performed 4 months after In-space implan-
tation. The second surgery curve breaks off after 11 months, when the
last of so far 10 patients underwent second surgery
1964 Acta Neurochir (2010) 152:1961–1967process implants have been developed. Wallis (Abbot
spine, Austin, TX), Coflex (formerly Intraspinous U;
Paradigm spine, New York, NY) [24], and Diam (Medtronic,
Tolochenanz, Switzerland) were primarily designed to
provide additional stability following conventional decom-
pression surgery [13]. Combination of IDP with endoscopic
decompression was described as a less invasive alternative
[17].
In order to further minimize surgical trauma, IPD
devices have been proposed as stand-alone technique,
avoiding the need for conventional decompression surgery
by indirect decompression through the distraction effect of
the implant itself. The distraction of the posterior column of
the spine (at level of the spinous processes and interspinous
ligaments) leads to widening of foraminal diameter and
reduces soft tissue compression of the spinal canal by
stretching of the ligamentum flavum [14, 16]. The X-stop
(Medtronic, Tolochenanz, Switzerland) is so far the best
studied device developed for this task [8, 23]. Recent
developments like the Aperius PercLID (Kyphon, Sunny-
vale, CA) and the In-space (applied in this study) are
designed for percutaneous implantation, further reducing
surgical trauma.
Intraoperative handling and complications
In our cohort the In-space device demonstrated short
implanting times (average of only 16.4 min per segment
in our cohort), virtually no blood loss and low complication
rate (only 1.1% misplacements and 2.2% failed implanta-
tion because of severely calcified interspinous ligament).
Average implantation times for other IPD devices are not
regularly reported in literature. Yano and colleagues [30]
report of average operation times of 44.7 min per segment
with a ceramic device, Kuchta and colleagues report that
operation time for implantation of the X-stop was “much
shorter when compared with the open decompression
group” but give no exact values. The short implantation
time of the In-space can be attributed to the percutaneous
implantation.
The complication rates of other implants for IPD are
likewise comparatively low. Barbagallo and colleagues [4]
report 11.6% complications for the X-stop device (four
device dislocations and four spinous process fractures in 69
patients), while Kuchta and colleagues [14] observed no
intraoperative complications, using the same implant in 175
patients. Korovessis and colleagues [13] observed one
involuntary dura leakage in 25 patients treated with the
Wallis implant in combination with conventional decom-
pression surgery.
Outcome
Unfortunately, we lack standardized outcome assessment
(in the form of well-established questionnaires, etc.).
However, like Verhoof and colleagues [27], we regarded
pain reduction, neurological function an improvement of
quality of life as the primary goals of IPD techniques, and
defined reoperation as the end point of failure. The outcome
in our cohort is comparable with those presented in the
literature for other interspinous process implants such as the
X-stop. Brussee and colleagues [5] report in their study of
65 patients who received an X-stop implant for lumbar
spinal stenosis and spinal claudication without spondylolis-
thesis of 9.2% of reoperations within a follow-up period of
1.0±0.75 years. Only 31.1% of the patients reported to be
satisfied with their outcome. Likewise, Verhoof and
colleagues [27] found good initial reduction of symptoms
in 8 of 12 patients (66.7%) treated for lumbar spinal
stenosis in the presence of spondylolisthesis. Within
24 months (mean follow-up, 30.3 months), 3 (25%) of
these had recurrent symptoms and finally 7 patients (58%)
required reoperation (microsurgical decompression and
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Fig. 5 a Results of a subgroup analysis directly after surgery. All
groups [all patients, patients with spondylolisthesis only, and patients
with (additional) low back pain at first presentation only] show a
comparatively good response to surgery, with about 70% good or
excellent results. b Situation at last follow-up (in average about 1 year
later). Both subgroups do fairly similar concerning lasting relief from
claudication. However, a significant number of these patients suffer
from lasting or new-onset low back pain (last column in the diagram)
Acta Neurochir (2010) 152:1961–1967 1965posterolateral fusion). Our results should be expected to be
somewhere in between these, because we included patients
with and without presence of spondylolisthesis in the
group. In our study, however, mild spondylolisthesis was
not associated with a worse outcome compared with the
entire collective.
Apart from this finding the similarity of the general
outcome in our study compared with those cited above,
using different implants suggests that the failure rate is an
expression of the limits of the principle of IPD itself, rather
than of individual design of the implants. The good initial
response might be related to a surgical placebo effect,
which was also recently observed in two prospective
studies comparing vertebroplasty with sham operation
[6, 12].
However, other authors report of far better results using
the X-stop implant. Kuchta and colleagues [14] report of
only 8 reoperations in 175 patients (4.6%). The authors of
this study suggest that this might partly be attributed to
careful patient selection and application of functional
(upright) magnetic resonance imaging for diagnosis. Like-
wise, other authors argue that implantation of IPD devices
should primarily be considered in cases that present with
typical spinal claudication with good reduction of pain
under flexion of the lumbar spine only [15]. As most of
these data are low-level evidence (like our own study), the
last word concerning IPD cannot yet be spoken. However,
presently there are 10 clinical trials with IPD devices going
on [26], and it can be hoped that the remaining questions
can be solved when these are completed.
Paralleling these findings, in our study of 42.2% patients
with lasting relief from claudication and radicular symp-
toms, 13.3% suffered of lasting or new-onset lumbago.
Whether the four cases of new-onset lumbago are a
complication of In-space implantation or whether this
belongs to the natural history of these patients cannot be
identified by this retrospective analysis. These four patients,
however, were the only ones who reported of this possible
complication at last follow-up; none of the patients who did
not experience lasting relief of claudication complained
about new-onset or worsened low back pain at last follow-
up. In the low back pain group in contrast, 26.7% of
patients reported of lasting relief also for this symptom after
In-space implantation. Thus, concerning the treatment of
low back pain, no evident suggestion can be derived from
this study.
The authors therefore suggest that in the presence of
only this low-level evidence and the high recurrence rate,
the device should primarily be used in clinical trials in order
to get more information concerning the optimal indication.
Patients who are anyway scheduled for implantation of an
In-space should be carefully informed about the above-
discussed limitation before surgery.
However, a large controlled, prospective trial comparing
the In-space device with the X-stop is under way and will
supply a more detailed view of short- and long-term results
of the In-space device [26].
Conclusions
The In-space device is a feasible and safe treatment option
of spinal claudication in patients who do not tolerate
microsurgical decompression surgery. The average opera-
tion time is very short, and intraoperative complications are
rare. However, overall outcome showed lasting relief of
claudication and radicular pain in only 42.2% after a
median follow-up of about 1 year. This is far worse than
has been shown even after long-term follow-up (>5 years)
of microsurgical decompression surgery (>90% lasting
relieve). Therefore, the authors suggest that at the time
being, the device should primarily be used in clinical trials
only, in order to get more information concerning the
optimal indication.
No suggestions can be made concerning the treatment of
low back pain, which might even progress after implanta-
tion of the device in some cases. The presence of mild
spondylolisthesis (Meyerding °1) did not show a negative
effect on the outcome.
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Comment
This study about interspinous devices is clear in its message: only
a minority of cases of older patients with degenerative stenosis,
not well operable by open surgery, profit from this little invasive
implant at an average f-up of 1 year. 2-year-results would
probably be even lower. Over enthusiastic publications in the
past about similar interspinius devices, mainly led by consultants
of the companies, are not credible in this reviewer's opinion, while
this study is carefully performed and self-critically analysed. It
shows the limits of "indirect" canal or foraminal decompression by
interspinous distraction: there are anatomical limits (how much can
be opened initially) and biomechanical limits (how long can the
opening be maintained) as there is some erosion of the implant-
spinous process-interface.
Michael Payer
Geneva, Switzerland
Acta Neurochir (2010) 152:1961–1967 1967